Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QUEST DIAGNOSTICS INCORPORATED

(DGX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
143.72(c) 145.71(c) 146.85(c) 145.36(c) 146.49(c) Last
1 095 070 1 359 651 1 293 636 2 854 595 1 247 486 Volume
+0.86% +1.38% +0.78% -1.01% +0.78% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 10 583 M - -
Net income 2021 1 944 M - -
Net Debt 2021 3 226 M - -
P/E ratio 2021 9,74x
Yield 2021 1,65%
Sales 2022 8 844 M - -
Net income 2022 918 M - -
Net Debt 2022 3 252 M - -
P/E ratio 2022 19,8x
Yield 2022 1,72%
Capitalization 18 018 M 18 018 M -
EV / Sales 2021 2,01x
EV / Sales 2022 2,41x
Nbr of Employees 50 000
Free-Float 75,0%
More Financials
Company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs),... 
More about the company
Ratings of Quest Diagnostics Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about QUEST DIAGNOSTICS INCORPORATED
10/22QUEST DIAGNOSTICS INCORPORATED : INC Management's Discussion and Analysis of Financial Con..
AQ
10/22QUEST DIAGNOSTICS INCORPORATED : Deutsche Bank Adjusts Quest Diagnostics PT to $160 From $..
MT
10/21Health Care Stocks Steady Pre-Bell Thursday
MT
10/21QUEST DIAGNOSTICS INCORPORATED : Posts Lower Q3 Earnings, Revenue; Updates 2021 Guidance
MT
10/21QUEST DIAGNOSTICS INCORPORATED : Reports Third Quarter 2021 Financial Results, Raises Outl..
PU
10/21QUEST DIAGNOSTICS : Q3 Earnings Snapshot
AQ
10/21QUEST DIAGNOSTICS INC : Results of Operations and Financial Condition, Financial Statement..
AQ
10/21Quest Diagnostics Incorporated Reports Earnings Results for the Third Quarter and Nine ..
CI
10/21Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on Oct..
CI
10/21QUEST DIAGNOSTICS INCORPORATED : Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q3 Revenue $..
MT
10/21QUEST DIAGNOSTICS INCORPORATED : Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q3 EPS $3...
MT
10/21QUEST DIAGNOSTICS : Reports Third Quarter 2021 Financial Results, Raises Outlook for Full ..
PR
10/21Quest Diagnostics Incorporated Revises Earnings Guidance for the Year 2021
CI
10/20QUEST DIAGNOSTICS INCORPORATED : Teams Up With Ginkgo Bioworks to Provide K-12 School COVI..
MT
10/20Quest Diagnostics to Provide Covid-19 School Testing Services in Texas
DJ
More news
News in other languages on QUEST DIAGNOSTICS INCORPORATED
10/21Quest Diagnostics affiche des résultats et un chiffre d'affaires inférieurs au troisièm..
10/21Earnings Flash (DGX) QUEST DIAGNOSTICS affiche un chiffre d'affaires de 2,77 milliards ..
10/21Quest Diagnostics Incorporated révise ses prévisions de bénéfices pour l'année 2021
10/20Quest Diagnostics s'associe à Ginkgo Bioworks pour proposer des tests COVID-19 dans les..
10/12Quotient nomme Ali Kiboro au poste de directeur financier
More news
Analyst Recommendations on QUEST DIAGNOSTICS INCORPORATED
More recommendations
Chart QUEST DIAGNOSTICS INCORPORATED
Duration : Period :
Quest Diagnostics Incorporated Technical Analysis Chart | DGX | US74834L1008 | MarketScreener
Technical analysis trends QUEST DIAGNOSTICS INCORPORATED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 146,49 $
Average target price 157,00 $
Spread / Average Target 7,17%
EPS Revisions
Managers and Directors
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Michael E. Prevoznik General Counsel, Senior VP-Legal & Compliance
Sector and Competitors